Is surgery necessary for breast 4a?

For breast mass grade 4, considering the possibility of malignant transformation, a puncture biopsy is required to confirm it. Grade 4 is further divided into three grades: a, b, and c. The risk of malignant transformation gradually increases, ranging from about 3% to 94%. 4a indicates mild abnormal malignancy. Solid lumps have 1 to 2 main manifestations of malignancy and require pathophysiological examination. The possibility of malignant transformation is 10%. So, is surgery necessary for breast 4a?

Is surgery necessary for breast 4a?

uncertain. Breast mass 4a means that the mass is mildly abnormal and malignant, with a 10%-20% chance of worsening. Level 4 patients have indications for surgery, but whether it is feasible needs to be determined based on family history and surgical risk factors. The recommended treatment method is to first perform a pathological puncture biopsy. Based on the biopsy results, if the results are good, regular follow-up should be performed, and the follow-up interval can be adjusted based on family history, breastfeeding history, obesity, etc. If the biopsy results confirm malignancy, surgery or other treatment methods should be selected based on the type of pathology, physical conditions, etc.

Breast 4a indicates an abnormal malignant tumor, with the probability of malignancy between 3% and 10%. Recommendation: Don’t rush into surgery. Wait until your condition is confirmed before making a decision. You can go to several large hospitals for physical examinations, and consider the advice of each doctor to decide whether to undergo surgery. Today's breast surgery treatment is excellent and there is no need to worry too much.

The treatment of breast nodules should first establish a clear diagnosis. Based on breast B-ultrasound and molybdenum target, some lumps are considered to be most likely benign lesions and can be considered for regular follow-up observation; some breast lumps require puncture biopsy to establish pathological characteristics, and further treatment plans are determined based on the pathological results. If it is a malignant tumor, multiple courses need to be combined according to the patient's condition to develop a distinctive comprehensive treatment plan, including surgery, radiotherapy, chemotherapy, endocrine therapy, and molecular targeted drug therapy.